Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma
Condition(s):Glioma, Malignant; Gliosarcoma; Astrocytoma of BrainLast Updated:September 17, 2019Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Glioma, Malignant; Gliosarcoma; Astrocytoma of BrainLast Updated:September 17, 2019Not yet recruiting
Condition(s):Adult Brainstem GliomaLast Updated:August 21, 2019Recruiting
Condition(s):Glioblastoma MultiformeLast Updated:February 17, 2021Completed
Condition(s):Extensive Stage Small Cell Lung CancerLast Updated:November 23, 2016Unknown status
Condition(s):Anaplastic Oligodendroglioma; Anaplastic OligoastrocytomaLast Updated:April 26, 2016Completed
Condition(s):Glioma; GlioblastomaLast Updated:October 8, 2020Recruiting
Condition(s):Neuroendocrine CarcinomasLast Updated:October 26, 2020Completed
Condition(s):Glioblastoma; Brain TumorLast Updated:February 1, 2021Not yet recruiting
Condition(s):GlioblastomaLast Updated:February 12, 2020Recruiting
Condition(s):MelanomaLast Updated:February 19, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.